(VXZ) iPath Series SP500 VIX - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US06746P6135

Futures, Volatility, Index

Description: VXZ iPath Series SP500 VIX October 19, 2025

The iPath® Series B S&P 500® VIX Mid-Term Futures ETN (BATS: VXZ) provides investors with exposure to a basket of CBOE VIX futures contracts of specified maturities, rather than to the VIX spot index itself. By tracking the performance of these futures, the ETN reflects the term-structure dynamics of market volatility rather than the instantaneous VIX level.

Key market-driven factors that typically affect VXZ include: (1) the shape of the VIX futures curve-contango environments generate negative roll yield, while backwardation can boost returns; (2) macro-economic stress events (e.g., Fed policy shifts, earnings season volatility spikes) that cause spikes in near-term VIX contracts and cascade through longer maturities; and (3) trading volume and open interest in the underlying VIX futures, which as of Q3 2025 average around 1.2 million contracts daily, influencing liquidity and bid-ask spreads for the ETN. The product carries a fee of 0.85% p.a. and is classified under “Trading-Miscellaneous” ETFs in the United States.

For a deeper, data-rich analysis of how VXZ behaves across different volatility regimes, consider exploring ValueRay’s interactive volatility-term-structure dashboards.

VXZ ETF Overview

Market Cap in USD 37m
Category Trading--Miscellaneous
TER 0.89%
IPO / Inception 2018-01-17

VXZ ETF Ratings

Growth Rating -27.9%
Fundamental -
Dividend Rating -
Return 12m vs S&P 500 -13.4%
Analyst Rating -

VXZ Dividends

Currently no dividends paid

VXZ Growth Ratios

Growth Correlation 3m -55.5%
Growth Correlation 12m 60.2%
Growth Correlation 5y -86.2%
CAGR 5y -20.18%
CAGR/Max DD 3y (Calmar Ratio) -0.35
CAGR/Mean DD 3y (Pain Ratio) -0.47
Sharpe Ratio 12m 0.94
Alpha -525.00
Beta 36.730
Volatility 22.93%
Current Volume 9.6k
Average Volume 20d 11.2k
Stop Loss 55.2 (-3.1%)
Signal 0.51

What is the price of VXZ shares?

As of November 02, 2025, the stock is trading at USD 56.97 with a total of 9,568 shares traded.
Over the past week, the price has changed by +2.26%, over one month by +2.74%, over three months by -2.62% and over the past year by +5.19%.

Is iPath Series SP500 VIX a good stock to buy?

Probably not. Based on ValueRay´s Analyses, iPath Series SP500 VIX (BATS:VXZ) is currently (November 2025) not a good stock to buy. It has a ValueRay Growth Rating of -27.88 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VXZ is around 41.19 USD . This means that VXZ is currently overvalued and has a potential downside of -27.7%.

Is VXZ a buy, sell or hold?

iPath Series SP500 VIX has no consensus analysts rating.

What are the forecasts/targets for the VXZ price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 49.4 -13.2%

VXZ Fundamental Data Overview October 20, 2025

Market Cap USD = 36.5m (36.5m USD * 1.0 USD.USD)
Beta = 36.73
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 36.5m USD (36.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 36.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 36.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 141.4% (E(36.5m)/V(36.5m) * Re(141.4%) + (debt-free company))
Discount Rate = 141.4% (= CAPM, Blume Beta Adj.) -> capped to 17.95%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for VXZ ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle